Resveratrol inhibits Cell Cycle Dynamics, Caspase Activation, and Programmed Cell Death: Implications for Cancer Treatment in MCF-7 Cells
SH Hamad, KM Nasir, AT Hameed… - Egyptian Journal of …, 2024 - journals.ekb.eg
Resveratrol is a plant-derived polyphenol known for its anti-inflammatory and anti-tumor
properties in laboratory models and living organisms. Recent studies suggest that certain …
properties in laboratory models and living organisms. Recent studies suggest that certain …
[HTML][HTML] Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer
Z Yu, Y Zhu, J Ji - Medicine, 2023 - journals.lww.com
Breast cancer (BRCA) is the most fatal malignancy of women. Immunotherapy has greatly
improved the prognosis of advanced BRCA. Cellular senescence contributes to …
improved the prognosis of advanced BRCA. Cellular senescence contributes to …
[PDF][PDF] 白藜芦醇对小鼠甲状腺乳头癌细胞移植瘤的抑制作用及机制研究
毛姗， 李扬， 丁韩梦， 赵永丽 - 中国普通外科杂志, 2023 - zpwz.net
摘要背景与目的: 白藜芦醇具有广泛的抗肿瘤作用, 其可抑制甲状腺乳头状癌细胞增殖和迁移,
但是其发挥作用的相关机制尚不清楚. 因此, 本研究探讨白藜芦醇对甲状腺乳头状细胞癌移植瘤 …
但是其发挥作用的相关机制尚不清楚. 因此, 本研究探讨白藜芦醇对甲状腺乳头状细胞癌移植瘤 …
[HTML][HTML] Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
L Lowe, JW LaValley, DW Felsher - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Tumor heterogeneity can contribute to the development of therapeutic resistance in cancer,
including advanced breast cancers. The object of the Halifax project was to identify new …
including advanced breast cancers. The object of the Halifax project was to identify new …